Noninvasive Detection of <i>EGFR</i> T790M in Gefitinib or Erlotinib Resistant Non–Small Cell Lung Cancer

Abstract

EGFR T790M can be detected using plasma DNA from gefitinib- or erlotinib-resistant patients. This noninvasive method may aid in monitoring drug resistance and in directing the course of subsequent therapy.